September 02, 2025
$33M Pfizer Antitrust Deal OK'd, First MDL Trial Date Set

A Pennsylvania federal judge has granted preliminary approval for a $33 million settlement between Pfizer and a class of direct purchasers claiming it fixed the prices of generic drugs, while also setting a date for the first bellwether trial in the antitrust litigation.

106 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Direct access to case information and documents.
All significant new filings across U.S. federal district courts, updated hourly on business days.
Full-text searches on all patent complaints in federal courts.
No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number:

Court:

Nature of Suit:

Multi Party Litigation:

Judge:

Firms

Companies

Government Agencies

Sectors & Industries:

View recent docket activity

Coverage

$33M Pfizer Antitrust Deal OK'd, First MDL Trial Date Set

Parties

Stay ahead of the curve